Name | diethyl 1-benzyl-1,4-dihydro-4-phenylpyridine-3,5-dicarboxylate |
---|---|
Synonyms | .diethyl 1-benzyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate |
Description | BML-278 is a SIRT1 activator (EC150: 1 μM). BML-278 increases H3K9 methylation and inhibits H3K9 acetylation in both the paternal and maternal pronucleus. BML-278 improves early embryonic development. BML-278 arrests the cell cycle at the G1/S phase, and reduces senescence in primary human mesenchymal cells. BML-278 reduces tubulin acetylation in U937 cells. BML-278 also increases mitochondrial density in murine C2C12 myoblasts[1][2]. |
---|---|
Related Catalog | |
Target |
SIRT1[1]. |
References |
Molecular Formula | C24H25NO4 |
---|---|
Molecular Weight | 391.46 |
Exact Mass | 391.17800 |
PSA | 55.84000 |
LogP | 4.11790 |
Precursor 0 | |
---|---|
DownStream 1 | |